WO2004022769A3 - Moyens de detection des processus neurodegeneratifs et leurs applications - Google Patents

Moyens de detection des processus neurodegeneratifs et leurs applications Download PDF

Info

Publication number
WO2004022769A3
WO2004022769A3 PCT/FR2003/002667 FR0302667W WO2004022769A3 WO 2004022769 A3 WO2004022769 A3 WO 2004022769A3 FR 0302667 W FR0302667 W FR 0302667W WO 2004022769 A3 WO2004022769 A3 WO 2004022769A3
Authority
WO
WIPO (PCT)
Prior art keywords
applications
same
neurodegenerative processes
detecting neurodegenerative
detecting
Prior art date
Application number
PCT/FR2003/002667
Other languages
English (en)
Other versions
WO2004022769A2 (fr
Inventor
Andre Delacourte
Nicolas Sergeant
Annick Wattez
Original Assignee
Inst Nat Sante Rech Med
Andre Delacourte
Nicolas Sergeant
Annick Wattez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Andre Delacourte, Nicolas Sergeant, Annick Wattez filed Critical Inst Nat Sante Rech Med
Priority to US10/526,899 priority Critical patent/US20060166283A1/en
Priority to AU2003278281A priority patent/AU2003278281A1/en
Priority to EP03769589A priority patent/EP1551994A2/fr
Publication of WO2004022769A2 publication Critical patent/WO2004022769A2/fr
Publication of WO2004022769A3 publication Critical patent/WO2004022769A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention se rapporte à de nouveaux marqueurs du processus neurodégénératif, consititués par la chaîne α de l'ATP synthase ayant subi des modifications. L'invention vise également des méthodes de détection, de diagnostic, des anticorps, des kits et leurs applications.
PCT/FR2003/002667 2002-09-06 2003-09-08 Moyens de detection des processus neurodegeneratifs et leurs applications WO2004022769A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/526,899 US20060166283A1 (en) 2002-09-06 2003-09-08 Means for detecting neurodegenerative processes and applications of same
AU2003278281A AU2003278281A1 (en) 2002-09-06 2003-09-08 Means of detecting neurodegenerative processes and applications of same
EP03769589A EP1551994A2 (fr) 2002-09-06 2003-09-08 Moyens de detection des processus neurodegeneratifs et leurs applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211100 2002-09-06
FR0211100A FR2844279A1 (fr) 2002-09-06 2002-09-06 Moyens de detection des processus neurodegeneratifs et leurs applications

Publications (2)

Publication Number Publication Date
WO2004022769A2 WO2004022769A2 (fr) 2004-03-18
WO2004022769A3 true WO2004022769A3 (fr) 2004-05-21

Family

ID=31725916

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/002667 WO2004022769A2 (fr) 2002-09-06 2003-09-08 Moyens de detection des processus neurodegeneratifs et leurs applications

Country Status (5)

Country Link
US (1) US20060166283A1 (fr)
EP (1) EP1551994A2 (fr)
AU (1) AU2003278281A1 (fr)
FR (1) FR2844279A1 (fr)
WO (1) WO2004022769A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
EP2596116A4 (fr) 2010-07-23 2014-03-19 Harvard College Procédés de détection de maladies/pathologies auto-immunes ou liées au système immunitaire
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
KR101240207B1 (ko) 2010-08-27 2013-03-06 고려대학교 산학협력단 알츠하이머병 조기진단용 단백질성 마커
AU2013274002A1 (en) 2012-06-15 2015-02-05 Harry Stylli Methods of detecting diseases or conditions
US20150141260A1 (en) 2012-06-15 2015-05-21 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
EP2965077B1 (fr) 2013-03-09 2022-07-13 Harry Stylli Procédés de détection de cancer
EP3385717A3 (fr) 2013-03-09 2018-10-24 Harry Stylli Procédés de detection du cancer de la prostate
EP3191846A4 (fr) 2014-09-11 2018-06-13 Harry Stylli Procédés pour détecter le cancer de la prostate
CA3090356A1 (fr) * 2018-03-11 2019-09-19 Koorosh Shahpasand Anticorps independants de la conformation diriges contre des proteines tau neurotoxiques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444431B1 (en) * 1998-05-19 2002-09-03 Duke University Angiostatin receptor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444431B1 (en) * 1998-05-19 2002-09-03 Duke University Angiostatin receptor

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANG SUN YOUNG ET AL: "Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 10, 8 March 2002 (2002-03-08), March 8, 2002, pages 8388 - 8394, XP002240871, ISSN: 0021-9258 *
KAGAWA Y ET AL: "REGULATION OF MITOCHONDRIAL ATP SYNTHESIS IN MAMMALIAN CELLS BY TRANSCRIPTIONAL CONTROL", INTERNATIONAL JOURNAL OF BIOCHEMISTRY, vol. 22, no. 3, 1990, pages 219 - 230, XP009010733, ISSN: 0020-711X *
KIM S H ET AL: "Decreased levels of complex III core protein 1 and complex V beta chain in brains from patients with Alzheimer's diseases and Down syndrome.", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, vol. 57, no. 12, November 2000 (2000-11-01), pages 1810 - 1816, XP002240872, ISSN: 1420-682X *
LEFEBVRE-LEGENDRE LINNKA ET AL: "Identification of a nuclear gene (FMC1) required for the assembly/stability of yeast mitochondrial F1-ATPase in heat stress conditions.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 9, 2 March 2001 (2001-03-02), pages 6789 - 6796, XP002240870, ISSN: 0021-9258 *
MOSER T EL AL: "Angiostatin binds ATP synthase on the surface of human endothelial cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, no. 6, 16 March 1999 (1999-03-16), pages 2811 - 2816, XP002121371, ISSN: 0027-8424 *
SCHÄGGER H ET AL: "Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis.", EUROPEAN JOURNAL OF BIOCHEMISTRY / FEBS. GERMANY 1 FEB 1995, vol. 227, no. 3, 1 February 1995 (1995-02-01), pages 916 - 921, XP001157497, ISSN: 0014-2956 *

Also Published As

Publication number Publication date
US20060166283A1 (en) 2006-07-27
AU2003278281A1 (en) 2004-03-29
FR2844279A1 (fr) 2004-03-12
AU2003278281A8 (en) 2004-03-29
EP1551994A2 (fr) 2005-07-13
WO2004022769A2 (fr) 2004-03-18

Similar Documents

Publication Publication Date Title
WO2007120265A3 (fr) Molécules codées permettant de détecter des substances cibles à analyser
WO2007044763A3 (fr) Systeme et procede permettant la detection de transactions frauduleuses
TWI317811B (fr)
WO2008048230A3 (fr) Procédés d'identification de cibles biologiques et instrumentation d'identification de cibles biologiques
WO2007044427A3 (fr) Détection d’acides nucléiques provenant de sang total
WO2006079049A3 (fr) Procedes et compositions pour detection a plage dynamique augmentee de molecules d'acide nucleique
WO2009058902A3 (fr) Procédés et dispositifs pour une détection d'analyte
WO2006117161A3 (fr) Nouvelles strategies d'etiquetage pour detection sensible d'analytes
WO2006031644A3 (fr) Sondes immobilisees et methodes de detection de proteines prions modifiees de maniere conformationnelle
WO2002054067A3 (fr) Detection d'analytes
WO2004055519A3 (fr) Marqueurs specifiques pour le cancer du pancreas
WO2007010379A3 (fr) Evaluation calorimetrique de micro-organismes et utilisation
WO2003083440A3 (fr) Procedes et compositions de detection et quantification d'analytes d'acides nucleiques
WO2002100242A3 (fr) Detection du cancer de l'ovaire sur la base des niveaux de alpha-haptoglobine
WO2004067570A3 (fr) Diagnostic et traitement du cancer de la prostate
WO2004022769A3 (fr) Moyens de detection des processus neurodegeneratifs et leurs applications
WO2005003394A3 (fr) Detection d'analytes cible a base de codes a barres biochimiques
WO2006119326A3 (fr) Compositions de sondes/amorces oligonucleotidiques et procedes de detection de polynucleotides
WO2002075274A3 (fr) Methode et trousse pour le suivi des maladies neurodegeneratives
WO2007001895A3 (fr) Anticorps monoclonaux, lignees cellulaires d'hybridome, procedes et trousses pour detecter la phytase
WO2005089505A3 (fr) Detection, isolement et utilisations de la renalase (monoamine oxydase de type c)
WO2004027081A3 (fr) Procedes et composition pour detecter des cibles
WO2007027796A3 (fr) Essai de ligature de proximite avec des conjugues peptidiques 'burrs' et des aptameres permettant une detection sensible de spores et de cellules cancereuses
WO2004046314A3 (fr) Procedes de detection de dimethylarginine asymetrique dans un echantillon biologique
WO2004024957A3 (fr) Procede de detection de micro-metastases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003769589

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003769589

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006166283

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10526899

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2003769589

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10526899

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP